Correlation Between Takeda Pharmaceutical and MannKind Corp
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and MannKind Corp, you can compare the effects of market volatilities on Takeda Pharmaceutical and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and MannKind Corp.
Diversification Opportunities for Takeda Pharmaceutical and MannKind Corp
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Takeda and MannKind is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and MannKind Corp go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and MannKind Corp
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the MannKind Corp. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 1.87 times less risky than MannKind Corp. The stock trades about -0.12 of its potential returns per unit of risk. The MannKind Corp is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 608.00 in MannKind Corp on August 31, 2024 and sell it today you would earn a total of 70.00 from holding MannKind Corp or generate 11.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Takeda Pharmaceutical Co vs. MannKind Corp
Performance |
Timeline |
Takeda Pharmaceutical |
MannKind Corp |
Takeda Pharmaceutical and MannKind Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Takeda Pharmaceutical and MannKind Corp
The main advantage of trading using opposite Takeda Pharmaceutical and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.The idea behind Takeda Pharmaceutical Co and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.MannKind Corp vs. Cue Biopharma | MannKind Corp vs. Eliem Therapeutics | MannKind Corp vs. Inhibrx | MannKind Corp vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |